Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (251-260 of 311) with videos related to

Pageof 32
Sort By:
British Journal of Cancer|October 1, 1996
Emotional support for cancer patients: what do patients really want?M L Slevin, S E Nichols, S M Downer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphomaKarl S Peggs, Irfan Kayani, Noha Edwards, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Blood|August 1, 1990
High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemiaA K McMillan, A H Goldstone, D C Linch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
British Journal of Cancer|October 3, 1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AMLC N Harrison, W Gregory, G V Hudson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
Leukemia & Lymphoma|May 11, 2002
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftmentP D Kottaridis, K Peggs, N Schmitz, et al.
Pageof 32

Showing results (251-260 of 311) with videos related to

Sort By:
Pageof 32
British Journal of Cancer|October 1, 1996
Emotional support for cancer patients: what do patients really want?M L Slevin, S E Nichols, S M Downer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphomaKarl S Peggs, Irfan Kayani, Noha Edwards, et al.
Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.
Blood|August 1, 1990
High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemiaA K McMillan, A H Goldstone, D C Linch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2003
Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activityKarl S Peggs, Stephen Mackinnon, Catherine D Williams, et al.
British Journal of Cancer|October 3, 1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AMLC N Harrison, W Gregory, G V Hudson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancerR L Souhami, H T Hajichristou, D W Miles, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
Leukemia & Lymphoma|May 11, 2002
Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: further follow-up from the original randomised study to assess engraftmentP D Kottaridis, K Peggs, N Schmitz, et al.
Pageof 32